<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="8660" href="/d/html/8660.html" rel="external">see "Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Drug information"</a> and <a class="drug drug_patient" data-topicid="11119" href="/d/html/11119.html" rel="external">see "Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="block spa drugH1Div" id="F57905820"><span class="drugH1">Special Alerts</span>
<div class="collapsible">
<span class="collapsible-title">Over-the-Counter Eye Drop Safety Alert</span>
<span class="collapsible-date">October 2023</span>
<div class="collapsible-wrap">
<p style="text-indent:0em;">The FDA is alerting patients and health care providers that multiple OTC ophthalmic drop products should no longer be used or purchased after agency investigators found insanitary conditions in the manufacturing facility and positive bacterial test results from environmental sampling of critical drug production areas in the facility. These findings show a potential risk of ophthalmic infections that could result in partial vision loss or blindness. Patients who have signs or symptoms of an ophthalmic infection after using these products should talk to their health care provider or seek medical care immediately. The affected products are marketed under various brand names (eg, CVS Health, Rugby, Velocity Health, etc.). The FDA has recommended that the manufacturer recall all lots of these products.</p>
<p style="text-indent:0em;">Further information, including the list of impacted products, may be found at <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrug-safety-and-availability%2Ffda-warns-consumers-not-purchase-or-use-certain-eye-drops-several-major-brands-due-risk-eye&amp;token=XBTQ2nxdijVMTMkEfLCAZ8oZqFD1X8%2BpWwEyUAh3GIU3oUT5uXJSL4R6SAxG5EZJeuJDgyjMb%2F3sDaOBM1kI3Wc9eyMY%2BSV07v9IZqMpcSNxScs8WsHvpZX2eqKcSZdTatAPjU9JXScZkwvqssmLs80%2BQR6ziC8h%2B4vEyQfkVGY%3D&amp;TOPIC_ID=17056" target="_blank">https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-certain-eye-drops-several-major-brands-due-risk-eye</a></p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Artificial Eye Ointment Safety Alert</span>
<span class="collapsible-date">February 2023</span>
<div class="collapsible-wrap">
<p style="text-indent:0em;">Global Pharma Healthcare is initiating a recall of Delsam Pharma’s Artificial Eye Ointment due to possible contamination with Verona Integron–mediated Metallo-β-lactamase– and Guiana extended-spectrum β-lactamase–producing carbapenem-resistant <i>Pseudomonas aeruginosa</i>. Adverse events, including ophthalmic infections, permanent vision loss, and a death with a bloodstream infection, have been reported.</p>
<p style="text-indent:0em;">More information is available at <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrug-safety-and-availability%2Ffda-warns-consumers-not-purchase-or-use-ezricare-artificial-tears-due-potential-contamination&amp;token=S9B4wvHJrulf5EpumAmKEBGV%2Be9PTrZSRt%2Bhisw1Hp6KIx6otjQDeyBxOO5zizDeb1MStGL0LOtF1MI0uSB3pjLyn%2BgyZ0BiivJSBXkthWzGyUfoXLJdh9I42B%2BgtzJyzoq4J%2FGsKxvy59qnqYruVaCmaBOYnb4sS8AfpTpsaDE%3D&amp;TOPIC_ID=17056" target="_blank">https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-ezricare-artificial-tears-due-potential-contamination</a>.</p></div>
</div>
</div>
<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F136850"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Advanced Eye Relief Dry Eye Environmental [OTC];</li>
<li>Advanced Eye Relief Dry Eye Rejuvenation [OTC];</li>
<li>Altalube [OTC];</li>
<li>Artificial Eye [OTC] [DSC];</li>
<li>Artificial Tears [OTC];</li>
<li>Bion Tears [OTC] [DSC];</li>
<li>FreshKote PF [OTC];</li>
<li>GenTeal Tears Mild [OTC];</li>
<li>GenTeal Tears Moderate [OTC];</li>
<li>GenTeal Tears Night-Time [OTC];</li>
<li>GenTeal Tears PF [OTC];</li>
<li>GenTeal Tears Severe Day/Night [OTC];</li>
<li>GoodSense Artificial Tears [OTC];</li>
<li>GoodSense Lubricant Eye Drops [OTC] [DSC];</li>
<li>HypoTears [OTC];</li>
<li>LubriFresh P.M. [OTC] [DSC];</li>
<li>Murine Tears [OTC];</li>
<li>Natural Balance Tears [OTC];</li>
<li>Natures Tears [OTC] [DSC];</li>
<li>Puralube [OTC];</li>
<li>Refresh Lacri-Lube [OTC];</li>
<li>Refresh P.M. [OTC];</li>
<li>Soothe Hydration [OTC];</li>
<li>Soothe [OTC];</li>
<li>Systane Balance [OTC];</li>
<li>Systane Complete [OTC];</li>
<li>Systane Hydration PF [OTC];</li>
<li>Systane Nighttime [OTC];</li>
<li>Systane Preservative Free [OTC];</li>
<li>Systane Ultra PF [OTC];</li>
<li>Systane Ultra [OTC];</li>
<li>Systane [OTC];</li>
<li>Tears Again [OTC] [DSC];</li>
<li>Tears Naturale II [OTC] [DSC];</li>
<li>Tears Naturale PM [OTC];</li>
<li>Vista Meibo Tears [OTC];</li>
<li>Vista Tears [OTC];</li>
<li>Viva-Drops [OTC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F999166"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Ophthalmic Agent, Miscellaneous</span></li></ul></div>
<div class="block don drugH1Div" id="F53462375"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Numerous products available, containing variable ingredients; ensure products containing propylene glycol or benzoate derivatives are NOT used in neonatal population; consult product specific labeling.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2026e947-0476-42ae-b347-5891350a9dc7">Ocular dryness/irritation or dry eye associated with ocular inflammation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ocular dryness/irritation or dry eye associated with ocular inflammation:</b> Limited data available (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21397805','lexi-content-ref-23419760','lexi-content-ref-20038941','lexi-content-ref-19357422']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21397805','lexi-content-ref-23419760','lexi-content-ref-20038941','lexi-content-ref-19357422'])">Ref</a></span>): Ophthalmic: Preservative-free dosage form:</p>
<p style="text-indent:-2em;margin-left:4em;">Gel, Solution: 1 drop into eye(s) as needed to relieve symptoms</p>
<p style="text-indent:-2em;margin-left:4em;">Ointment: Apply small amount to inside of the eyelid(s) one or more times daily</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F136856"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="9cb5011c-76dd-4870-922e-ff966180865d">Ocular dryness/irritation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ocular dryness/irritation:</b> Infants, Children, and Adolescents: Ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">Gel; Solution: 1 to 2 drops into eye(s) as needed to relieve symptoms</p>
<p style="text-indent:-2em;margin-left:4em;">Ointment: Apply small amount (~<sup>1</sup>/<sub>4</sub> inch) to inside of the eyelid(s) one or more times daily</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0e09d393-553e-41f4-becf-f1c788b86049">Dry eye associated with ocular inflammation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dry eye associated with ocular inflammation (eg, blepharitis, conjunctivitis, keratitis):</b> Limited data available: Infants, Children, and Adolescents: Ophthalmic 1 to 2 drops into eye(s) at least twice daily or as needed to relieve symptoms (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19357422']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19357422'])">Ref</a></span>)</p></div>
</div>
</div>
<div class="block doa drugH1Div" id="F136852"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="8660" href="/d/html/8660.html" rel="external">see "Artificial tears (Ophthalmic lubricants: solutions, gels, ointments): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="9cb5011c-76dd-4870-922e-ff966180865d">Ocular dryness/irritation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Ocular dryness/irritation: </b>Ophthalmic: 1 to 2 drops into eye(s) as needed to relieve symptoms.</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F136840"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F136837"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Contact lens wearers: Ophthalmic solutions may contain benzalkonium chloride which may be absorbed by contact lenses. Remove contact lenses before using.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson, 2002; Lucente 2000; Shelley, 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Preservative free formulations: Preservative free formulations are preferred in patients with severe dry eye or patients on multiple eye drops for chronic disease. Once opened, single use containers should be discarded; do not reuse.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Self-medication (OTC use): When used for self-medication (OTC), stop use and contact healthcare provider if changes in vision, eye pain, continued redness or irritation occur, or if the condition worsens or persists for more than 72 hours. To avoid contamination, do not touch tip of container to any surface. Replace cap after using. Do not use if solution is cloudy or changes color.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878336"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F136845"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;">Gel, ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears Severe Day/Night: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (8 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (10 mL, 15 mL)</p>
<p style="text-indent:-2em;margin-left:2em;">Ointment, ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">Altalube: Petrolatum 83% and mineral oil 15% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Artificial Eye: Petrolatum 83% and mineral oil 15% (3.5 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears Night-Time: Petrolatum 94% and mineral oil 3% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Puralube: Petrolatum 85% and mineral oil 15% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Refresh Lacri-Lube: Petrolatum 83% and mineral oil 15% (3.5 g, 7 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Tears Naturale PM: Petrolatum 94% and mineral oil 3% (3.5 g) [contains lanolin]</p>
<p style="text-indent:-2em;margin-left:2em;">Ointment, ophthalmic [preservative free]:</p>
<p style="text-indent:-2em;margin-left:4em;">HypoTears: Petrolatum 83% and mineral oil 15% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">LubriFresh P.M.: Petrolatum 83% and mineral oil 15% (3.5 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">Puralube: Petrolatum 85% and mineral oil 15% (1 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Refresh P.M.: Petrolatum 83% and mineral oil 15% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Nighttime: Petrolatum 94% and mineral oil 3% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Tears Again: Petrolatum 83% and mineral oil 15% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:2em;">Solution, ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">Advanced Eye Relief Dry Eye Environmental: Glycerin 1% (15 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;">Advanced Eye Relief Dry Eye Rejuvenation: Glycerin 0.3% and propylene glycol 1% (30 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;">Artificial Tears: Glycerin 0.2%, hydroxypropyl methylcellulose 0.2%, and polyethylene glycol 400 1% (15 mL) [contains benzalkonium chloride, edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears Mild: Dextran 70 0.1%, and hydroxypropyl methylcellulose 2910 0.3% (15 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears Moderate: Dextran 70 0.1%, glycerin 0.2%, and hydroxypropyl methylcellulose 2910 0.3% (15 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">GoodSense Artificial Tears: Polyvinyl alcohol 0.5% and povidone 0.6% (15 mL) [contains benzalkonium chloride, edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">HypoTears: Polyvinyl alcohol 1% and polyethylene glycol 400 1% (30 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;">Murine Tears: Polyvinyl alcohol 0.5% and povidone 0.6% (15 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;">Natural Balance Tears: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% (15 mL) [contains benzalkonium chloride, edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">Natures Tears: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3 % (15 mL [DSC]) [contains benzalkonium chloride, edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">Soothe Hydration: Povidone 1.25% (15 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Balance: Propylene glycol 0.6% (10 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Complete: Propylene glycol 0.6% (10 mL) [contains edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Ultra: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (4 mL, 10 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (5 mL, 15 mL, 30 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Tears Again: Polyvinyl alcohol 1.4% (15 mL [DSC], 30 mL [DSC]) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;">Tears Naturale II: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% (15 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">Vista Tears: Polyethylene glycol 0.4% and propylene glycol 0.3% (10 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Vista Meibo Tears: Propylene glycol 0.6% (10 mL)</p>
<p style="text-indent:-2em;margin-left:2em;">Solution, ophthalmic [preservative free]:</p>
<p style="text-indent:-2em;margin-left:4em;">Bion Tears: Dextran 70 0.1% and hydroxypropyl methylcellulose 2910 0.3% per 0.4 mL (28s [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">FreshKote PF: Polyvinyl alcohol 2.7% and povidone 2% (10 mL) [contains edetate disodium]</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears Mild: Dextran 70 0.1%, and hydroxypropyl methylcellulose 2910 0.3% (36s)</p>
<p style="text-indent:-2em;margin-left:4em;">GenTeal Tears PF: Dextran 70 0.1% and Hydroxypropyl methylcellulose 2910 0.3% (36s)</p>
<p style="text-indent:-2em;margin-left:4em;">GoodSense Lubricant Eye Drops: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (30s [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">Soothe: Glycerin 0.6% and propylene glycol 0.6% per 0.6 mL (28s)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Hydration PF: Polyethylene glycol 400 0.4% and propylene glycol 0.3% (30s)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Preservative Free: Polyethylene glycol 400 0.4% and propylene glycol 0.3% per 0.4 mL (28s, 30s)</p>
<p style="text-indent:-2em;margin-left:4em;">Systane Ultra PF: Polyethylene glycol 400 0.4% and propylene glycol 0.3% per 0.4 mL (24s [DSC], 25s, 60s)</p>
<p style="text-indent:-2em;margin-left:4em;">Viva-Drops: Polysorbate 80 1% (0.5 mL, 10 mL)</p></div>
<div class="block geq drugH1Div" id="F136834"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323001"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (GenTeal Tears Severe Day/Night Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $1.25</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Systane Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $1.24</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Altalube Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">85-15% (per gram): $0.82</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Bion Tears PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1-0.3% (per each): $0.53</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (FreshKote Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.7-2% (per mL): $2.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (FreshKote PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.7-2% (per mL): $3.36</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (GenTeal Tears Moderate PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1-0.3% (per each): $0.33</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (GenTeal Tears Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1-0.2-0.3% (per mL): $0.47</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (GenTeal Tears PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1-0.3% (per each): $0.30</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Polyvinyl Alcohol Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.4% (per mL): $0.49 - $0.66</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Refresh Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.4-0.6% (per each): $0.37</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Complete Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.6% (per mL): $1.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Hydration PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $1.17</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $0.77</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Preservative Free Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per each): $0.42</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Ultra Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $0.92</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Systane Ultra PF Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4-0.3% (per mL): $1.07</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52612265"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Ophthalmic: Wash hands thoroughly before administration; do not touch tip of container to the eye or any surface; replace cap after use. Some products should not be used with contact lenses; consult specific product information.</p></div>
<div class="block sts drugH1Div" id="F13273197"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at room temperature.</p></div>
<div class="block usep drugH1Div" id="F53565524"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Ophthalmic lubricant; for temporary relief of burning and eye irritation due to dry eyes; protectant against further irritation (OTC: FDA approved in adults; refer to product-specific information regarding FDA approval in pediatric patients); has also been used for symptomatic treatment of dry eye associated with conjunctivitis, blepharitis, and keratitis</p></div>
<div class="block mst drugH1Div" id="F136862"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Isopto® Tears may be confused with Isoptin® </p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13298775"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6218082"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pha drugH1Div" id="F13273115"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Products contain demulcents (ie, cellulose derivatives, dextran 70, gelatin, polyols, polyvinal alcohol, or povidone); usually a water-soluble polymer, applied topically to the eye to protect and lubricate mucous membrane surfaces and relieve dryness and irritation</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58842770"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Duratears | Hypotears Plus | Isotears | Optifresh (Jamjoom) | Systane | Tears Naturale</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-3960626">
<a name="3960626"></a>Alade SL, Brown RE, Paquet A. Polysorbate 80 and E-Ferol toxicity. <i>Pediatrics.</i> 1986;77(4):593-597.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/3960626/pubmed" id="3960626" target="_blank">3960626</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Artificial Tears [prescribing information]. Lake Forest, IL: Akorn, Inc; January 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6423951">
<a name="6423951"></a>Centers for Disease Control (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product.<i> MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/6423951/pubmed" id="6423951" target="_blank">6423951</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21397805">
<a name="21397805"></a>Cogen MS, Parker JS, Sleep TE, Elsas FJ, Metz TH Jr, McGwin G Jr. Masked trial of topical anesthesia for retinopathy of prematurity eye examinations. <i>J AAPOS</i>. 2011;15(1):45-48.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/21397805/pubmed" id="21397805" target="_blank">21397805</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23419760">
<a name="23419760"></a>Craiglow BG. Ichthyosis in the newborn. <i>Semin Perinatol</i>. 2013;37(1):26-31.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/23419760/pubmed" id="23419760" target="_blank">23419760</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Freshkote (polyvinyl alcohol and povidone) [prescribing information]. Fort Worth, TX: Eyevance Pharmaceuticals, LLC; received May 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20038941">
<a name="20038941"></a>Harvey HB, Shaw MG, Morrell DS. Perinatal management of harlequin ichthyosis: a case report and literature review. <i>J Perinatol</i>. 2010;30(1):66-72.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/20038941/pubmed" id="20038941" target="_blank">20038941</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12534540">
<a name="12534540"></a>Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/12534540/pubmed" id="12534540" target="_blank">12534540</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10985636">
<a name="10985636"></a>Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/10985636/pubmed" id="10985636" target="_blank">10985636</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17508120">
<a name="17508120"></a>"Management and Therapy of Dry Eye Disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)," <i>Ocul Surf</i>, 2007, 5(2):163-78.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/17508120/pubmed" id="17508120" target="_blank">17508120</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Puralube (artificial tears) [prescribing information]. Minneapolis, MN: Perrigo; August 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19357422">
<a name="19357422"></a>Sethuraman U, Kamat D. The red eye: evaluation and management. <i>Clin Pediatr (Phila)</i>. 2009 Jul;48(6):588-600. doi:10.1177/0009922809333094<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/19357422/pubmed" id="19357422" target="_blank">19357422</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7746084">
<a name="7746084"></a>Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. <i>Lancet</i>. 1995;345(8980):1312-1313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/artificial-tears-ophthalmic-lubricants-solutions-gels-ointments-pediatric-drug-information/abstract-text/7746084/pubmed" id="7746084" target="_blank">7746084</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Systane (artificial tears) [prescribing information]. Ft. Worth, TX: Alcon Laboratories, Inc; June 2016.</div>
</li>
<li>
<div class="reference">
                  Systane Ultra (polyethylene glycol and propylene glycol) [prescribing information]. Ft. Worth, TX: Alcon Laboratories, Inc; received April 2020.</div>
</li></ol></div><div id="topicVersionRevision">Topic 17056 Version 134.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
